4/A

OWNERSHIP DOCUMENT

Company: Cellectar Biosciences, Inc.
Filed: March 5, 2020
Period of Report: February 3, 2020
Accession Number: 0001104659-20-029696

View Document ↗ View on SEC.gov ↗